• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Sex as a predictor of response to cancer immunotherapy.

作者信息

McQuade Jennifer L, Daniel Carrie R, Hess Kenneth R, Davies Michael A

机构信息

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

出版信息

Lancet Oncol. 2018 Aug;19(8):e376. doi: 10.1016/S1470-2045(18)30483-2.

DOI:10.1016/S1470-2045(18)30483-2
PMID:30102226
Abstract
摘要

相似文献

1
Sex as a predictor of response to cancer immunotherapy.性别作为癌症免疫治疗反应的预测指标。
Lancet Oncol. 2018 Aug;19(8):e376. doi: 10.1016/S1470-2045(18)30483-2.
2
Sex as a predictor of response to cancer immunotherapy.
Lancet Oncol. 2018 Aug;19(8):e378. doi: 10.1016/S1470-2045(18)30531-X.
3
Sex as a predictor of response to cancer immunotherapy.性别作为癌症免疫治疗反应的预测指标。
Lancet Oncol. 2018 Aug;19(8):e375. doi: 10.1016/S1470-2045(18)30443-1.
4
Sex as a predictor of response to cancer immunotherapy.
Lancet Oncol. 2018 Aug;19(8):e379. doi: 10.1016/S1470-2045(18)30445-5.
5
Sex as a predictor of response to cancer immunotherapy.性别作为癌症免疫治疗反应的预测指标。
Lancet Oncol. 2018 Aug;19(8):e377. doi: 10.1016/S1470-2045(18)30517-5.
6
Sex as a predictor of response to cancer immunotherapy - Authors' reply.性别作为癌症免疫治疗反应的预测指标——作者回复
Lancet Oncol. 2018 Aug;19(8):e380-e381. doi: 10.1016/S1470-2045(18)30535-7.
7
Sex as a predictor of response to cancer immunotherapy.
Lancet Oncol. 2018 Aug;19(8):e374. doi: 10.1016/S1470-2045(18)30446-7.
8
Genomic landscape associated with potential response to anti-CTLA-4 treatment in cancers.与癌症中抗CTLA-4治疗潜在反应相关的基因组图谱。
Nat Commun. 2017 Oct 19;8(1):1050. doi: 10.1038/s41467-017-01018-0.
9
Sex-driven differences in immunological responses: challenges and opportunities for the immunotherapies of the third millennium.性驱动的免疫反应差异：对第三个千年的免疫治疗的挑战和机遇。
Int Rev Immunol. 2015 Mar;34(2):134-42. doi: 10.3109/08830185.2015.1018417.
10
Does a patient's sex predict the efficacy of cancer immunotherapy?患者的性别能否预测癌症免疫疗法的疗效？
Lancet Oncol. 2018 Jun;19(6):716-717. doi: 10.1016/S1470-2045(18)30270-5. Epub 2018 May 16.

引用本文的文献

1
Topics of Interest in Women With Myeloproliferative Neoplasms.骨髓增殖性肿瘤女性患者的关注主题。
Am J Hematol. 2025 Jun;100 Suppl 4(Suppl 4):74-87. doi: 10.1002/ajh.27665. Epub 2025 Mar 14.
2
Sex differences in adverse events among cancer patients receiving immune checkpoint inhibitors: the MOUSEION-07 systematic review and meta-analysis.癌症患者接受免疫检查点抑制剂治疗的不良反应中的性别差异：MOUSEION-07 系统评价和荟萃分析。
Sci Rep. 2024 Nov 16;14(1):28309. doi: 10.1038/s41598-024-71746-z.
3
Extracellular Acidosis Differentially Regulates Estrogen Receptor β-Dependent EMT Reprogramming in Female and Male Melanoma Cells.
细胞外酸中毒对雌性和雄性黑色素瘤细胞中雌激素受体β依赖性上皮-间质转化重编程具有不同调节作用。
Int J Mol Sci. 2022 Dec 6;23(23):15374. doi: 10.3390/ijms232315374.
4
Sex-biased adaptive immune regulation in cancer development and therapy.癌症发生发展与治疗中的性别偏向性适应性免疫调节
iScience. 2022 Jul 4;25(8):104717. doi: 10.1016/j.isci.2022.104717. eCollection 2022 Aug 19.
5
Evaluation of prognostic factors in patients undergoing first-line chemotherapy for advanced biliary tract cancer: a retrospective analysis from a South American cancer centre.晚期胆管癌一线化疗患者预后因素的评估：来自南美癌症中心的回顾性分析
Ecancermedicalscience. 2022 Jan 17;16:1345. doi: 10.3332/ecancer.2022.1345. eCollection 2022.
6
Sex-associated molecular differences for cancer immunotherapy.癌症免疫治疗的性别相关分子差异。
Nat Commun. 2020 Apr 14;11(1):1779. doi: 10.1038/s41467-020-15679-x.
7
Modifiable Host Factors in Melanoma: Emerging Evidence for Obesity, Diet, Exercise, and the Microbiome.黑色素瘤的可改变宿主因素：肥胖、饮食、运动和微生物组的新证据。
Curr Oncol Rep. 2019 Jul 1;21(8):72. doi: 10.1007/s11912-019-0814-2.
8
Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal?抗程序性细胞死亡蛋白 1 治疗在转移性黑色素瘤和非小细胞肺癌患者中的耐受性的性别差异：我们都平等吗？
Oncologist. 2019 Nov;24(11):e1148-e1155. doi: 10.1634/theoncologist.2019-0094. Epub 2019 Apr 29.